Performance of broad-spectrum targeted next-generation sequencing in lower respiratory tract infections in ICU patients: a prospective observational study
Authors:
Open Access
- 4 June 2025
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-13
Abstract
Purpose: Targeted next-generation sequencing (tNGS) has emerged as an advanced diagnostic technique. While tNGS is increasingly recognized as a valuable tool for detecting infections, its most relevant clinical indications remain underdefined. This study aimed to evaluate the clinical utility of tNGS for lower respiratory tract infections (LRTIs). Methods: We conducted a prospective, observational study to evaluate the clinical diagnostic value of broad-spectrum targeted Next-Generation Sequencing (bstNGS) covering 1872 microorganisms in critically ill patients with LRTIs. We compared the microbial detection performance of bstNGS, mNGS, and traditional culture methods in bronchoalveolar lavage fluid (BALF). Additionally, we used the odds ratio (OR) from multiple logistic regression to assess the impact of relevant clinical variables on the detection of pathogens by bstNGS. We also examined the correlation between bstNGS pathogen detection results and clinical outcomes. Results: Between August 23, 2023, and April 24, 2024, samples from 150 patients were analyzed. bstNGS detected 96.33% and 91.15% of the microorganisms discovered by mNGS and culture respectively, and was capable of identifying microorganisms with even lower loads. According to the diagnostic criteria, bstNGS, mNGS, and culture methods detected pathogens in 87.33%, 82.00%, and 46.00% of the samples respectively. Moreover, the NGS methods demonstrated a stronger pathogen detection ability compared to culture (p < 0.05). Further comparing the diagnostic performance of the three methods, bstNGS exhibited higher diagnostic accuracy than both mNGS (90.67% vs 86.00%, p < 0.05) and culture (90.67% vs 49.33%, p < 0.0001). Multivariate analysis revealed that immunocompromise was associated with a lower efficiency of pathogen detection by bstNGS (p = 0.04), while other included clinical features had no significant correlation with bstNGS detection. Additionally, compared with patients in whom no pathogen was detected, patients in whom a pathogen was detected by bstNGS were associated with better outcomes of antibiotic treatment (89.68% vs. 62.50%; OR 7.53, 95% CI 1.41–45.30; p = 0.02). Conclusion: This study shows the effectiveness of bstNGS in detecting pathogens of LRTIs, as well as its value as a potential auxiliary diagnostic method in the ICU.Keywords
Funding Information
- Guangdong Natural Science Foundation (2023A1515011252)
- The National Natural Science Foundation of China (82272186)
- the Guangdong Clinical Research Center for Critical Care Medicine (2020B1111170005)
- the Key Areas R&D Program of Guangdong (2023B1515230005)
- the Sun Yat-sen University Clinical Research Program 5010 (2024006)
This publication has 35 references indexed in Scilit:
- Enhancing lower respiratory tract infection diagnosis: implementation and clinical assessment of multiplex PCR-based and hybrid capture-based targeted next-generation sequencingEBioMedicine, 2024
- Effectiveness of metagenomic next-generation sequencing in the diagnosis of infectious diseases: A systematic review and meta-analysisInternational Journal of Infectious Diseases, 2024
- MultiPrime: A reliable and efficient tool for targeted next‐generation sequencingiMeta, 2023
- European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTIIntensive Care Medicine, 2023
- Viral reactivation in the lungs of patients with severe pneumonia is associated with increased mortality, a multicenter, retrospective studyJournal of Medical Virology, 2022
- Targeted next generation sequencing is comparable with metagenomic next generation sequencing in adults with pneumonia for pathogenic microorganism detectionJournal of Infection, 2022
- Metagenomic next-generation sequencing for accurate diagnosis and management of lower respiratory tract infectionsInternational Journal of Infectious Diseases, 2022
- Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in patients with pulmonary infections: Systematic review and meta-analysisInternational Journal of Infectious Diseases, 2022
- Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infectionsJournal of Advanced Research, 2021
- Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patientsJournal of Infection, 2021